Japan Results Roundup: Reduced Forex Impact, Uncertain US Tariff Outlook

But Most Mainstays Maintain Solid Growth

 
• By Lisa Takagi
  
Japan Q1 results
Mainstays lead fiscal Q1 growth at Japan's top pharma firms. (Shutterstock)

More from Earnings

More from Japan